Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores

por Broekman, K.E., van Kruchten, M., van Tinteren, H., Sessa, C., Jalving, M., Reyners, A.K.L.
Publicado 2021

Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature

por Osinga, T. E., Oosting, S. F., van der Meer, P., de Boer, R. A., Kuenen, B. C., Rutgers, A., Bergmann, L., Oude Munnink, T. H., Jalving, M., van Kruchten, M.
Publicado 2022

Enhanced pulmonary uptake on (18)F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

por Venema, C. M., de Vries, E. F. J., van der Veen, S. J., Dorrius, M. D., van Kruchten, M., Schröder, C. P., Hospers, G. A. P., Glaudemans, A. W. J. M.
Publicado 2019

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

por Koleva-Kolarova, R G, Greuter, M J W, van Kruchten, M, Vermeulen, K M, Feenstra, T, Buskens, E, Glaudemans, A W J M, de Vries, E F J, de Vries, E G E, Hospers, G A P, de Bock, G H
Publicado 2015